Feb 05, 2024 / NTS GMT
Presentation
Feb 05, 2024 / NTS GMT
=====================
Corporate Participants
=====================
* Atsushi Kitamura
Astellas Pharma Inc. - CFO
* Claus Zieler
Astellas Pharma Inc. - Chief Commercial Officer
* Hiromitsu Ikeda
Astellas Pharma Inc. - Corporate Head of Advocacy & Relations
* Tadaaki Taniguchi
Astellas Pharma Inc. - Chief Medical Officer
=====================
Conference Call Participants
=====================
* Akinori Ueda
Goldman Sachs Group, Inc., Research Division - Equity Analyst
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Hiroyuki Matsubara
Nomura Securities Co. Ltd., Research Division - Research Analyst
* Kasumi Haruta
UBS Investment Bank, Research Division - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Koichi Mamegano
BofA Securities, Research Division - Analyst
* Miki Sogi
Sanford C. Bernstein
Astellas Pharma Inc
(TSE:4503)
円
2,295.5
+62 (+2.78%)
Market Cap: 4.11 Tn
Enterprise Value: 4.39 Tn
PE Ratio: 14.15
PB Ratio: 2.24
GF Score: 82/100 Q3 2024 Astellas Pharma Inc Earnings Presentation Transcript
Feb 05, 2024 / NTS GMT
Release Date Price:
円1700
(+1.19%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot